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Resumo 
 O complexo Burkholderia cepacia (Bcc) é constituído por, pelo menos, 18 espécies do 
género Burkholderia, estas bactérias são agentes patogénicos oportunistas capazes de causar 
infeções severas e, frequentemente, morte em doentes com fibrose quística (CF). A fibrose quistica 
é provocada pela mutação do gene codificante do regulador de condutância transmembranar 
(CFRT) que causa a sua ausência na membrana apical das células epiteliais. Esta doença é 
caracterizada pela inflamação e infeção crónica das vias respiratórias por Pseudomonas aeruginosa 
e Burkholderia cepacia. 
 Agentes patogénicos como B. cepacia apresentam muitos fatores de virulência que os 
ajudam a estabelecer infeção e a invadir células hospedeiras. Entre os muitos fatores já estudados 
estão as adesinas triméricas autotransportadas (TAAs). Estas proteínas são responsáveis pela 
adesão às células hospedeiras e, também pela formação de biofilme, invasão e sobrevivência 
destas bactérias dentro de células hospedeiras. Estas adesinas são o único mecanismo de 
aderência a células hospedeiras conhecido em Burkholderia, para além da adesina de 22KDa 
associada a pili, também já estudada. No entanto, apesar de já demonstrada a importância das 
TAAs para capacidade de adesão e invasão de B. cenocepacia a porta de entrada utilizada por estes 
patogéneos ainda não é conhecida, e, por isso, neste trabalho as jangadas lípidicas foram 
estudadas como uma possível opção. 
 A análise do genoma da estirpe B. cenocepacia J2315 revelou a existência de um 
agrupamento de genes no qual a lipoproteína de membrana BCAM0220 e da adesina BCAM0219 
formam um operão, sugerindo, portanto, a assistência da lipoproteina na biogénese da adesina 
BCAM0218, como o já estudado entre as proteínas SadA e SadB em Salmonella.   
 Neste trabalho foi possível perceber que as jangadas lípidicas não são utilizadas como 
portas de entrada na ligação das TAAs na infeção de células epiteliais por B. cenocepacia. No 
entanto, não foi possível estudar a sugerida relação entre as proteínas BCAM0220 e BCAM0219, 
pois as ferramentas necessárias não foram obtidas. 
 
Palavras-chave: Burkholderia cenocepacia; adesina trimérica autotransportada; fibrose quística; 
jangadas lípidicas 
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Abstract 
 The Burkholderia cepacia complex (Bcc) comprises, at least, 18 species of the Burkholderia 
genus, these bacteria are opportunistic pathogens able to cause severe and often lethal respiratory 
infections in cystic fibrosis (CF) patients. CF is a genetic disorder that causes the lack of the 
transmembrane conductance regulator (CFRT) protein at the apical membrane of epithelial cells.  
This disease is characterized by chronic airway infection, which can be caused by a variety of 
microorganisms, such as Pseudomonas aeruginosa and Burkholderia cepacia, and persistent airway 
inflammation. 
 Pathogenic bacteria, as Burkholderia bacteria possess a vast array of virulence determinants 
that are used to cause infection. Although, pathogenicity in these bacteria is still poorly 
understood many virulence determinants have already been described, among them there are the 
trimeric autotransporter adhesins (TAAs). The TAAs are responsible for not only adherence, but 
biofilm formation, invasion and survival within eukaryotic cells, as well.  Additionally, the only 
other virulence factor responsible for adhesion already described in Burkholderia is the 22KDa 
cable pili associated adhesin.  Previous studies demonstrated that TAAs are necessary for B. 
cenocepacia's ability to adhere and invade airway epithelial cells, nevertheless, the gateways that 
these bacteria use to do so have yet not been described, therefore, in this study, lipid rafts were 
exploited as a possibility.   
 Furthermore, the study of the genome of the B. cenocepacia J2315 strain revealed the 
existence of a putative adhesin cluster in which the TAA BCAM0219 gene and the outer-membrane 
lipoprotein BCAM0220 are an operonic structure suggesting a possible assistance of the  
BCAM0220 lipoprotein in BCAM0219 TAA biogenesis, as it has been described for the SadA and 
SadB Salmonella proteins. 
 In this study, it was possible to determine that lipid rafts are not used as gateways, but, 
unfortunately, it was not possible to study BCAM0220 and BCAM0219 interaction as the necessary 
tools were not obtained. 
 
Key-words:  Burkholderia cenocepacia; trimeric autotransporter adhesin; cystic fibrosis; lipid rafts 
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1. Introduction 
 
 1.1 Burkholderia cepacia complex 
The Burkholderia genus contains a group of versatile gram-negative bacteria that are often 
found in soil, water and plant rhizopheres. Some of its members are able to able to degrade major 
xenobiotic pollutants, enhance crop growth and survive in man-made products as pharmaceuticals. 
Within this genus there’s the Burkholderia cepacia complex (Bcc) a group of closely related 
species of human opportunistic pathogens, capable of causing chronic and severe infection 
especially in cystic fibrosis and immunocompromised patients, but, in contrast, it cannot affect 
healthy individuals (Coenye & Lipuma, 2003; Mahenthiralingam et al., 2008; O’Sullivan & 
Mahenthiralingam, 2005). 
 
1.2 Taxonomy  
In 1950, Burkholder described Pseudomonas cepacia as the responsible agent of bacterial 
onion rot (Burkholder, 1950). However, with the advent of new techniques as rRNA-DNA 
hybridization and various rRNA gene sequencing methods taxonomists realized that the 
Pseudomonas genus comprised five species clusters. Then, as consequence Pseudomonas cepacia 
and other species were transferred to the new Burkholderia genus. Later, several researchers noted 
a remarkable diversity among strains identified as Burkholderia cepacia using traditional and 
molecular identification approaches (Coenye et al., 2001). In fact, this single species was shown to 
consist of at least five different genetic species designated as genomovars, in consequence, the 
group of the five species was named the B. cepacia complex (Bcc)(Vandamme et al., 1997).  
Numerous methods were used to establish correct relationships between strains and 
improve their identification. Among the genotyping methods applied there’re the 16S rRNA and 
recA gene based analyses as well as the MLSA (multilocus sequence analysis) and MLST (multilocus 
sequence typing) approaches. The 16S rRNA and recA gene based analysis both confirmed 
phylogenetic relatedness of Bcc complex members, nevertheless, the 2% intraspecies diversity in 
their 16S rRNA gene overlapped recA gene restriction profiles, rendering these methods ineffective 
(Coenye et al., 2001; Vandamme & Dawyndt, 2011). 
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. 
Fig. 1: Bcc complex 16S rRNA based phylogenetic tree. 
 
 
  Instead, the MLSA approach uses allelic profiles nucleotide sequences capable to reveal 
similarities between strains of different species and genera. In contrast, the MLST approach can be 
specifically developed to measure similarities and differences, that make it able to clearly 
differentiate all Bcc closely related species and differentiate strains (Baldwin et al., 2005; 
Vandamme & Dawyndt, 2011). These allowed establishing the Bcc complex in seventeen species 
(Fig 1). 
Furthermore, not only by recA gene sequence analysis the B. cenocepacia was subdivided 
into four phylogenic clusters IIIA to IIID, but almost all clinically relevant isolates belong in the IIIA 
and IIIB groups but, also,  MLST analysis of the Bcc has led to understand that the Edinburgh-
Toronto lineage (ET-12), a notorious epidemic strain, to which belongs the species Burkholderia 
cenocepacia K-56, appears to fit within five different sequences types (ST), being the ST-28 and ST-
32 strains the accounted for multiple globally distinct locations (Mahenthiralingam et al., 2008).   
 Finally, B. pseudomultivorans a new species within the Bcc complex was just identified by 
using some of the analysis methods referred as recA, 16S rRNA sequence analysis and MLSA 
(Peteers et al., 2013). 
 
1.3 Ecology and environmental diversity 
  The Burkholderia species complex can be found in soil, water and the rhizosphere of plants, 
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where they develop different types of non-pathogenic interactions with plants by colonizing its 
roots, leaves and stems (Coenye & Vandamme, 2003). These species are found in diverse habitats 
because of its assumed capacity to use a wide range of compounds as carbon sources. In fact, this 
species metabolic adaptability is enabled by its multireplicon genome that harbours a vast array of 
insertion sequences that promote genomic plasticity (Chiarini et al., 2006). 
 However, Bcc species are disproportionately distributed in their various habitats; for 
instance B. cenocepacia   is prevalent in cystic fibrosis (CF) lung whereas B. ambifaria is most 
common in plant rhizosphere, like in both maize and tomato rhizosphere as well as associated with 
sugarcane (Caballero-Mellado et al, 2007; Castro-González et al., 2011; Chiarini et al., 2006; 
Ramette et al., 2005) (Tab. 1).  Most of the rhizosphere associated species have the ability of 
nitrogen fixation, to nodulate legumes and to degrade aromatic compounds, as well as the 
potential for bio inoculation and bio control (Suárez-Moreno et al., 2012). 
            Tab. 1: B. cepacia complex species diverse sources (Chiarini et al., 2006;Vial et al., 2011). 
Species Source CF Non -CF 
B. ambifaria Rhizosphere,soil,humans X X 
B. anthina 
Rhizosphere, soil ,water, hospital, 
environment, humans 
X X 
B. cenocepacia 
Rhizosphere, soil,water, hospital, 
environment, humans 
X X 
B. cepacia 
Rotten onion,rhizosphere, 
soil,water, humans 
X X 
B. dolosa Rhizosphere,humans X  
B. multivorans Rhizosphere, soil,water, humans X X 
B. pyrrocinia 
Rhizosphere, soil,water, humans 
 
X  
B. stabilis Hospital environment, humans X X 
B. vietnamiensis 
Rhizosphere, soil,water, humans 
 
X X 
B. ubonensis Soil   
B. latens No environmental strain reported X  
B. diffusa Soil, water X X 
B. arboris Rhizosphere, soil, water X X 
B. seminalis Rice rhizosphere X  
B. metallica No environmental strain reported X  
B. contaminans Soil, water, animal X X 
B. lata Soil, water, ﬂower X X 
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 All species from the Bcc complex have been isolated from CF sputum cultures, with 
the exception of B. ubonensis, nevertheless, some species are more often found in CF patients than 
others. B. cenocepacia and B. multivorans, despite showing an highly disproportionate distribution 
within clinical isolates from CF and non-CF patients, are the most frequently found species, 
together accounting for at least 70% of infected patients in the United States, however, B. 
cenocepacia is the most commonly recovered species from CF patients across the world (Fig.2) 
(Lipuma et al., 2010; Reik et al., 2005). 
Fig. 2: Worldwide distribution of Bcc species in CF patients selected populations (Mil-Homens, 2012). 
  
However, it is also important to note that B. gladioli, phenotypically close but not 
phylogenetically a member of the Bcc complex, is now more regularly found in CF patients across 
USA than most of the Bcc complex species, and B. cepacia is comparatively seldom found (Lipuma, 
2010). Also, there are some Burkholderia bacteria that even by genetic analyses cannot be 
properly assigned to one of the current species; therefore, these strains likely belong to new 
species within the Bcc complex.  Nevertheless, although Bcc complex species are frequently found 
in CF the most commonly found bacterial species is Pseudomonas aeruginosa, and, for example, in 
the United States, in 2008, 52.5% of patients included in the Cystic Fibrosis Foundation (CFF) 
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Patient Registry were reported to have had P. aeruginosa recovered from sputum culture (Lipuma, 
2010). 
 Furthermore, B. cenocepacia and B. multivorans infection incidence has changed during the 
last years as, while B. cenocepacia previously accounted for the majority of Burkholderia infection 
in CF, now both in the United States and the United Kingdom the recovery of B. multivorans 
surpasses that of  B. cenocepacia (Reik et al., 2005; Govan & Jones, 2007). The reasons for the 
predominance of these two species among CF patients are unknown in spite of the very close 
phylogenetic relatedness of species within the Bcc complex (Reik et al., 2005). However, the 
disproportion between B. cenocepacia and B. multivorans and the other species representation 
suggests a better capability of human infection (Lipuma et al., 2001; Reik et al., 2005). 
 Lastly, several studies identified common strains of Burkholderia bacteria in CF patients 
among them are epidemic ET12 strains, which are prevalent in the United Kingdom and eastern 
Canada, and other specific strains as the ST04 and the CZ1 were recovered from CF patients in 
Canada and Prague, respectively (Lipuma, 2010). 
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1.4 Cystic fibrosis physiology  
 Cystic fibrosis is the most common lethal autosomal recessive genetic disorder in 
Caucasians population caused by the cystic fibrosis transmembrane conductance regulator (CFRT) 
gene mutation, that results in the absence of the CFRT protein at its proper cellular location, the 
apical membrane (Boucher, 2004; Lyczak et al., 2002) . The majority of CF mutations are associated 
with the CFRT's protein misfolding, the most common mutation, the ΔF508 mutation was the first 
to show problems in polypeptide maturation and translocation to the suitable cellular site 
(Boucher, 2004). 
 This disease is characterized by sinopulmonary chronic infection, which can be caused by a 
variety of microorganisms, such P. aeruginosa, Staphylococcus aureus and members of the Bcc. 
Such microorganisms are often, capable of causing life-threatening respiratory tract infections and, 
ultimately, 80 to 90% of CF infected patients succumb due to respiratory failure brought on by 
chronic bacterial infection and associated airway inflammation (Lyczak et al., 2002). 
 In healthy lungs, however, the airways below the first bronchial division remain sterile, 
because of the existing defence mechanisms that ward off the virus and bacteria present in the air 
we breathe. Lung defences consist not only of mechanic defences but, also, of cellular immune 
mechanisms as dendritic cells, neutrophils and macrophages recruited by signalling molecules in 
the airway surface liquid (ASL) (Wine, 1999). The ASL is a mucus gel and periciliary sol that forms a 
thin covering layer of the airways, consisting of proteases/antiproteases, oxidants/antioxidants, 
antibiotics, and antibodies that work together to inactivate or destroy pathogens, without 
collateral damage to the lungs. Additionally, the ASL is propelled towards the mouth by 
coordinated ciliary beating which aided by cough helps the mucociliary clearance of the airways. In 
contrast, in CF most of the airways are infected, thus making it difficult and impossible to clear the 
infections (Wine, 1999). 
 The CFRT gene product is an anion channel, member of the ATP binding cassette (ABC) 
family, which uses ATP hydrolysis energy to change between conducting and non-conducting 
conformations, but in CF this channel its affected, explaining a wide range of symptoms (Lyczak et 
al., 2002; Wine, 1999). As an anion channel the CFRT product is important to both absorption and 
secretion because it allows the flow of anions to in or out of the cells. Nevertheless, in CF the CFRT 
its defective which results in a loss of CFRT-mediated anion conductance, thus explaining, for 
example, the high levels of electrolytes, such as chloride, in CF patients sweat. There are, at least, 
two hypotheses that explain the CFRT role in cystic fibrosis lung disease and both view this anion 
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channel role in salt absorption to be of importance, indicating that this protein has, at least, two 
functions those being to conduct Cl- ions and to regulate epithelial Na+ channels (EnaC) (Lyczak et 
al., 2002; Wine, 1999).  
Firstly, the high salt hypothesis (Fig. 3A) considers that the defective or missing CFRT allows 
salt levels in the ASL to be similar to those in the plasma (Fig.3A1) which interferes with the 
antibiotics present in the ASL (Fig.3A2). Secondly, the low volume hypothesis states (Fig.3B) that, 
although, CF ASL exhibits plasma-like salt levels (Fig.3B1), the CFRT mutations eliminate the CFRT’s 
inhibition of the EnaC channels, consequently, increasing Na+ transport, which in turn, increases Cl- 
transport and water absorption (Fig.3B2). As stated before the ASL has two components a mucus 
layer which entraps the pathogens and particles we breathe and the pericilliary liquid that acts as a 
cell surface coating and helps cilliary beating.  In consequence, the volume depletion that happens 
in CF airways surfaces induces a slower mucus transport and bacterial clearance, and mucus 
adhesion to the airway surface which results in airway obstruction (Boucher, 2004; Mall et al., 
2004). Furthermore, the ASL bactericidal activity is affected in CF because of the high salt 
concentration which impairs the activity of the bactericidal factors (Smith et al., 1996). Hence, the 
various CFRT mutations lead to infection and obstruction of the airways caused by the decreased 
bactericidal activity and accelerated fluid absorption that depletes the ASL volume (Boucher, 2004; 
Smith et al., 1996; Wine, 1999). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3: Two different Hypothesis of how CFRT mutation affects the ASL. A) The high salt hypothesis shows 
that normal ASL has low levels of salt as result of salt absorption (A1) In CF (A2) salt is poorly absorbed 
which results in a high salt concentration in ASL that disturbs natural mucosal antibiotics. B) The low volume 
hypothesis proposes that the normal ASL has salt levels approximately equal to plasma (B1). In CF (B2) the 
CFRT inhibition of EnaC channel is lost resulting in an abnormally elevated isotonic fluid that leads to the 
depletion of the ASL and defective mucociliary clearance (Adapted from Wine, 1999). 
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 1.5 B. cenocepacia host-cell interactions 
Infection, in cystic fibrosis (CF) patients can be caused by opportunistic pathogens like the 
members of the Burkholderia cepacia complex. In addition, some Bcc strains are associated with 
heightened transmissibility, poor clinical outcome, and increased risk of developing cepacia 
syndrome, as well, as being associated with bacteraemia in severely ill non-CF patients; thus 
suggesting tropism of these organisms to injured lungs (Ganesan & Sajjan, 2012). Strains of the 
ET12 lineage, like B. cenocepacia K56-2, preferentially enter CF airway epithelial cells (Fig.4B) 
(Sajjan et al., 2004; Sajjan et al., 2006). So, to survive in an intracellular environment these species 
evades host defences by employing several mechanisms involved in intracellular survival and 
replication (Fig.4C). 
 Firstly, Bcc complex bacteria have the ability to infect host cells, through the development 
of biofilms (Fig.4A) (Schwab et al., 2002). To develop a mature biofilm these bacteria need to form 
microcolonies which are often found within the mucus layer, on the surface of epithelial cells or 
deeper in the cell layer, indicating cellular invasion (Sajjan et al., 2004).  Normal apical mucus 
prevents bacteria from reaching the underlying epithelial cells, due to factors that kill and/or 
prevent replication of bacteria (Sajjan et al., 2004). However, CF mucus traps bacteria but it does 
not reduce its density or damage, so, trapped bacteria have longer periods to replicate and 
increases chances of adherence and invasion of the underlying epithelial cells (Sajjan et al., 2004).  
 Once, these bacteria aggregate and show characteristics of a distinct biofilm the bacteria 
are able to invade airway epithelial cells (Schwab et al., 2002). Then, after internalized through 
phagocytosis by both professional phagocytes and epithelial cells, Bcc bacteria, as B. cenocepacia, 
subverts trafficking of young phagossomes (Burns et al., 1996; Martin & Mohr, 2000; Schwab et al., 
2002). B. cenocepacia either diverts young phagossomes from their normal trafficking or exits from 
early endossomes to reside in the cytoplasm or enter vesicles. In addition, these bacteria are, also, 
capable to evade the endocytic pathway, prevent maturation of lysossomes, inhibit the 
acidification of autophagossomes and to be found in perinuclear area, suggesting that these 
bacteria traffic and replicate in the endoplasmatic reticulum (ER) (Sajjan et al., 2006). 
 Besides, invading able to disrupt the actin cytoskeleton and to disrupt or rearrange the 
intermediate filaments (Sajjan et al., 2004; Schwab et al., 2002; Schwab et al., 2003), as well as, 
migrate across polarized respiratory epithelium expressing tight junctions (Kim et al., 2005). For 
example, in order to cause infection, B. multivorans promotes the disruptions of actin filaments 
during epithelial host cell invasion; once the actin network is disrupted biofilm-dependent invasion 
ceases to be effective, suggesting that this invasion mechanism is dependent on an intact 
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cytoskeleton (Schwab et al., 2003). Furthermore, CF epithelium infected with B. cenocepacia K56-2 
showed bacteria between and within cells, despite the presence of mucus. These bacteria were 
free or surrounded by intermediate filaments, indicating that their movement may involve 
disruption or rearrangement of the intermediate filaments (Sajjan et al., 2004). 
 As previously referred, Bcc complex members are able to migrate across the epithelium 
(Fig.4D) (Kim et al., 2005).  B. cenocepacia infects polarized respiratory epithelium by 
compromising epithelial integrity through the disruption of intracellular tight junctions, which, 
results in a steady decline of the transepithelial electrical resistance. In fact, cell layers infected 
with B. cenocepacia revealed its colocalization with occludin which appeared to be disrupted and 
translocated to the cytoplasm. Although, infected cells show disrupted occluding localization, tight 
junction organization was not disturbed indicating the absence of a secreted toxin capable of tight 
junction disruptiom, as seen in other pathogens as C. difficile (Kim et al., 2005; Sears et al., 2000). 
In contrast, to such pathogens these bacteria do not cause disruption of the cell layer due to cell 
death or injury, instead B. cenocepacia is capable of occludin dephosphorylation and its dislocation 
from focal points along the tight junctions’ axis. Therefore, leading to the disruption of tight 
junction integrity, that in turn allows the migration of bacteria through the epithelium (Kim et al., 
2005). 
 Moreover, B. cenocepacia infection produces distinct responses from healthy well 
differentiated airway cell cultures and CF cell cultures. In normal cell cultures with apical mucus 
layer B. cenocepacia bacteria are not able to decrease transephitelial resistance, however, in CF cell 
cultures these bacteria’s infection caused the decrease of transepithelial resistance and increase of 
permeability; especially when the apical mucus layer was removed (Sajjan et al., 2004). 
 Additionally, infected CF cells, whether with depleted mucus layer or not, demonstrated an 
increased interleukin-8 (IL-8) expression. Also, only Bcc complex strains that persisted on the 
epithelial cells, elicited a significant IL-8 response, implying that these bacteria have to bind and/or 
invade the underlying epithelial cells to promote IL-8 release (Sajjan et al., 2004).  
Finally, strains as B. cenocepacia J2315 and B. cepacia J2540 are not only able to invade 
epithelial cells, but, also, capable of macrophage invasion. Nevertheless, while B. cepacia J2540 
was not able to survive and replicate intracellularly. B. cenocepacia J2315 was able to survive and 
increase its numbers located intercellularly 24 hours after infection (Martin & Mohr, 2000). 
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Fig. 4: Burkholderia sp. mechanism of airway epithelia infection.  A) Bacterial attachment to the cell apical 
mucus and biofilm development. B) Airway epithelial cell invasion. C) Intracellular survival and replication. D)  
Bacterial migration across the epithelium by means of occludin desphosphorylation and its dislocation from 
focal points of the tight junction axis 
 
 
Moreover, once chronic colonization, in CF patients, is settled the eradication of these 
organisms is unlikely. Therefore, several combinations of antibiotic and non-antibiotic compounds 
are currently being tested against Burkholderia and Pseudomonas. Burkholderia are often difficult 
to eradicate as they usually are intrinsically resistant to multiple antibiotics (Moss, 1995; Govan & 
Deretic; 1996, Ramsey, 1996). Nevertheless, Pseudomonas infections often begin by resembling 
bronchitis that is generally cleared by antibiotics, but, later replaced by more difficult to eradicate 
chronic colonizers of the airways (Burns et al., 2001). The usual chemotherapeutic strategies apply 
one or more classes of antibiotics in which the most common pairing is a β-lactam with an amino 
glycoside for which increased efficacy has been demonstrated in CF patients (reviewed in George 
et al., 2009). Furthermore, a in vitro study demonstrated excellent synergy of polyethylenimine 
with β-lactams, cephalosporins, novobiocin, or chloramphenicol, which resulted in diminished 
minimal inhibitory concentrations (MICs)  to the these antibiotics against  P.  aeruginosa. On the 
other hand the bismuth-thiols showed in vitro synergy with tobramycin against the Bcc complex, as 
well as, possessing advantages against biofilm activity and micromolar MICs (Veloira et al., 2003). 
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1.6 Burkholderia cepacia complex genome 
 Burkholderia species have some of the largest and most complex bacterial genomes studied. 
All Burkholderia species possess large genomes ranging from 6 to 9 Mb and it's this huge genetic 
capacity that grounds out their great versatility both in natural environments and in disease. Bcc 
species, also, separate its DNA into two or more chromosomal replicons which may add greater 
flexibility in the gain, loss and expression of genes (Mahenthiralingam et al., 2008). 
  As B. cenocepacia is the most clinically important member of the B. cepacia complex that 
causes infections in cystic fibrosis patients. The genome of B. cenocepacia J2315, a multidrug 
resistant clinical isolated of the ET12 lineage, has been studied to provide insight into the success 
of this strain as an opportunistic pathogen. The complete genome of B. cenocepacia J2315 consists 
of 3 circular chromosomes (3.9Kb, 3.2Kb and 876bp) and a plasmid (92,661bp) (Tab. 2) (Holden et 
al., 2009). Analysis of all 4 replicons revealed several encoded initial coding sequences (CDS) of 
which 126 are pseudogenes or partial genes. On chromosome 1 diverse functions are encoded 
those  range from Rnase E, ribossomal protein,  fatty acid/phospholipid synthesis proteins to 
elongation factor P, while  chromosome 2 and 3 encode greater proportion of accessory functions 
(Holden et al., 2009). 
 Comparative genomics of the J2315 genome with Bcc and other Burkholderia genomes 
showed that the level of orthology identified correlated with their taxonomic relatedness, as the 
largest number of orthologous coding sequences (CDSs) were identified in the Bcc species, 63 to 
78% of total CDSs. In addition, the level of orthology is the greatest on chromosome 1 with 
chromosome 2 and 3 being progressively more divergent, despite the distribution of orthologs on 
the different replicons being similar to that seen in various Burkholderia species. Furthermore, 
pairwise alignments demonstrated that chromosome 1 displays the highest level of conservation, 
followed by the second and third chromosomes which showed lower levels of overall conservation 
and no conservation of gene order, respectively (Holden et al., 2009).   
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Tab. 2: General features of the Burkholderia cenocepacia J2315 genome (Holden et al; 2009) 
Properties 
Chromosome 
1 
Chromosome 
2 
Chromosome 
3 
Plasmid Total 
Size (bp) 3,870,082 3,217,062 875,98 92,66 8,055,782 
G+C  content (%) 66.7 67.9 67.9 62.6 66.9 
Number of CDSs 3,54 2,85 776 99 7,26 
Coding (%) 86.1 86.4 86.0 78.6 85.9 
Average gene length 
(bp) 
958 985 986 763 970 
rRNA 
4 
(16S-23S-5S)    
1 
(16S-23S-5S) 
1 
(16S-23S-5S) 
0 
6 
(16S-23S-5S) 
tRNA 66 6 2 0 74 
Miscellaneous RNA 15 3 2 1 21 
Pseudogenes and 
partial genes 
56 41 23 6 126 
IS elements 51 16 11 1 79 
 
 Horizontal transfer of DNA has been seen as an important factor in the success of B. 
cenocepacia in disease and spread between patients. In the studied J2315 genome 14 regions have 
been identified as putative genomic islands. For example, the cci island, a 44kb region, has been 
shown to be involved in infection as it has attributed functions like antibiotic resistance and a 
quorum sensing system (Holden et al., 2009). 
 Moreover, the annotation of close repeats in the B. cenocepacia J2315 sequence revealed 
1056 repeats, that vary from a minimum of 10bp to a maximum of 50 068bp, from which 422 are 
close DNA repeats, among these repeats 45 genes are potentially involved in virulence (Mil-
Homens et al., 2010). 13 of these genes were included in the putative antigen class and the 
product of four genes was found to vary in length, due differences in the number of tandem 
repeats. In addition, the putative antigens BCAM0219 and BCAM0223, annotated as trimeric 
autotransporter adhesins (TAAs) were absent from other genomes (Mil-Homens et al., 2010). 
 The full transcriptomic analysis of B. cenocepacia demonstrated that this pathogen alters 
the expression of 10% of the 7176 genes within its genome when it grows in CF sputum (Drevinek 
et al., 2008). Among the genes with altered expression were not only  genes with putative 
functions in antimicrobial resistance, iron uptake, protection against reactive oxygen and nitrogen 
species, secretion and motility, but also, novel uncharacterized genes which included  a 
transmembrane ferric reductase  that's possibly implicated  in  iron  metabolism, a protease that  
may be important  in  host  tissue  destruction,  an  organic hydroperoxide resistance gene, an 
oxidoreductase and a nitrite/sulfite reductase that may be relevant  in  resistance  to  the  host  
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defences (Drevinek et al., 2008). This transcriptomic study, also, demonstrated that many of the 
gene pathways activated by B. cenocepacia in response to growth in CF sputum correlated with 
virulence mechanisms, as for example, antibiotic efflux and degradation (Drevinek et al., 2008).    
 Furthermore, the pilus associated adhesin gene, adhA, was found to be activated in sputum 
suggesting its importance for bacterial growth, however, in contrast, there was a  lack  of  
activation  of  the  structural  components  of cable pilus operon of B. cenocepacia J2315 (Drevinek 
et al., 2008). In addition, genes on the cci island were not upregulated and the quorum-sensing 
systems described in B. cenocepacia did not demonstrate differences in expression which 
suggested that these virulence factors are not important in the modelled early stages of infection. 
Nevertheless, the upregulation of flagellar apparatus genes was detected suggesting that motility 
helps B. cenocepacia bacteria to maintain a more invasive phenotype during infection (Drevinek et 
al., 2008). 
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1.7 Virulence determinants 
 Although the pathogenicity of these bacteria is not fully understood a vast range of 
virulence determinants have already been studied. Those include extracellular and cell surface 
polysaccharides, nutrient acquisition and metabolic pathways, resistance to antimicrobials and 
proteins.     
 1.7.1 Quorum sensing 
 Bacteria use quorum sensing (QS) systems as a means to quickly adapt to a given 
environment, as the QS systems are often responsible for siderophore, protease and lipase 
production, and biofilm formation (de Kievit & Iglewski., 2000). In the Bcc complex the most widely 
distributed QS system is the cepIR system, initially, described in B. cenocepacia, which regulates 
extracellular virulence factors as zinc metalloproteases and biofilm formation that contribute to 
lung injury (Sokol et al., 2003). 
 1.7.2 Siderophores 
 CF patients lungs are iron restricted environments for prospective pathogens as the Bcc 
species. In order to be able to cause infection B. cepacia complex members possess efficient iron 
uptake mechanisms. These  bacteria display up to four types of siderophore – ornibactin,the most 
prevalent (Darling et al., 1998), pyochelin, cepabactin and cepaciachelin – that employ nearly all 
iron-binding groups present in most siderophores (Thomas, 2007). Moreover B. cenocepacia 
ornibactin mutants showed attenuated virulence against both C. elegans and G. mellonella 
(Uehlinger et al., 2009) and  a mutation in the ferric-ornibactin receptor severely hindered the 
growth of B. cenocepacia K56-2 (Visser et al., 2004). 
 1.7.3 Lipopolysaccharides 
 Lipopolysaccharides (LPS) are glycolipids, capable of inducing a strong immune response 
which contributes to host cell damage. In B. cenocepacia the LPS plays an important role in 
virulence, since mutants on genes concerning LPS biosynthesis have damaged virulence in rat agar 
bead model, C. elegans and G. mellonella (Loutet et al., 2006; Hunt et al., 2004., Uehlinger et al., 
2009). The B.cenocepacia species LPS is, as well, able to affect the level of phagocytosis and induce 
a strong cytokine inflammatory response that varies within the B. cenocepacia strain (Bamford et 
al., 2007; De Soyza et al., 2004; Saldías et al., 2009). 
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1.7.4 Exopolysaccharides 
 Exopolysaccharides (EPS) usually have two functions, to form a barrier around bacterial 
cells or colonies and to interfere with the host defences through their chemical characteristics 
(Chiarini et al., 2004). Most of Bcc strains including  B. cenocepacia, have been shown to mostly 
produce one type of EPS named cepacian, which is often produced along with other 
polysaccharides species (Fig.5) (Chiarini et al., 2004; Herasimenka et al; 2007, Zlosnik et al; 2008). 
B. cenocepacia is capable to exhibit both mucoid and non-mucoid phenotypes, which are related 
with the high and low EPS production, respectively (Cérantola et al., 2000; Zlosnik et al., 2008). The 
mucoid phenotype is associated with delayed lung clearance in a mouse model, and interferes with 
the binding and/or with phagocytosis by neutrophils and mononuclear phagocytes, development 
of microcolonies, establishment of thick and mature biofilms in vitro and substratum adherence 
(Conway et al., 2004; Cunha et al., 2004). Furthermore, non-mucoid B.cenocepacia bacteria are 
associated with increased disease severity while the mucoid phenotype can be associated with 
persistance in CF airways (Cunha et al., 2004, Zlosnik et al., 2008). 
   
Fig. 5: Chemical structure of the EPS produced by Bcc (Adapted from Herasimenka et al., 2007). 
 
1.7.5 Flagella 
 B. cepacia is a motile organism, and motility is mediated by polar flagella. Flagella in   
B.cepacia affects both swarm capacity and invasion of host cells, as flagellum-mediated motility is 
necessary for the establishment of contact with host cells and, then, subsequent bacterial entry; 
therefore contributing to the adherence of bacteria to epithelial airways, invasion of deeper tissue, 
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and penetration of the abundant mucus layer in CF patients that covers the airways, due to 
inefficient mucociliary clearance (Tomich et al., 2002). 
 Furthermore, B. cenocepacia flagella contribute for both infectivity and inflammation, as it 
contributes to the virulence in an in vivo infection model, and induction IL-8 secretion through 
interaction with TLR5 may contribute to lung damage (Urban et al., 2004). 
1.7.6 Pili and the associated 22KDa adhesin 
 A study demonstrated that  B. cepacia isolates carrying the cblA gene, and,the 22KDa 
adhesin, with cable pili phenotype are capable to adhere to CF damaged lung tissue, by binding to  
cytokeratin 13 (CK) which is enriched in CF lung tissue (Sajjan et al., 2000). The 22KDa adhesin is 
sufficient for the binding, adherence and the transmigration across squamous epithelium of B. 
cenocepacia bacteria but it alone does not account for the optimal binding to the  CK13 receptor, 
as, both cable pili and the adhesin are necessary for optimal binding and transmigration through 
the epithelia (Urban et al., 2005) Moreover, both the 22KDa adhesin and the cable pili contribute 
to IL-8 response, inflammation and persistence of B. cenocepacia in vivo and both account for 
spread of infection through the airways (Goldberg et al.,  2011). 
1.7.7 Secreted proteins 
  The Burkholderia species express at least two proteases, the ZmpA and ZmpB zinc 
metalloproteases, which are able to directly degrade important host tissues components like 
collagen and fibronectin as well as cleave immune response agents as immunoglobulins (e.g. IgA 
and IgG), therefore, leading to lung tissue damage and impairment of immune host defences, that 
in turn contribute to the virulence of these bacteria (Corbett et al., 2003; Kooi et al., 2005; Kooi et 
al., 2006). Furthermore, different secretion types that support pathogenicity, virulence and 
persistence of diverse species of Bcc bacteria have been described, as for example type III, VI and 
IV secretions systems (Sajjan et al., 2008, Scharwz et al., 2010,  Stevens et al., 2004 ; Schell et al., 
2007; Ulrich et al., 2004). 
 1.7.8 Antimicrobial resistance 
 Bcc bacterial infections are difficult to contain because many strains are multidrug resistant 
either because of intrinsic or acquired mechanisms being the usually administered therapy  
frequently composed of two or three different agents, even though the optimal had not yet been 
found (Avgeri et al; 2009, Sass et al;2011)  B. cenocepacia exposure to several antibiotics revealed a 
wide range of resistance mechanisms as for example, beta-lactamases, phosphohydrolases, efflux 
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pumps and phenylacetic acid pathways that could be used as potential therapeutic targets. (Sass et 
al., 2011).   
 1.7.9 Biofilms 
 As already referred in the chapter Cystic Fibrosis and Burkholderia spp. Infection these 
bacteria ability to develop biofilms plays an important role in its capacity to cause infection. In 
addition, B. cenocepacia and B. multivorans besides being the most abundant strains isolated from 
CF patients are, also, the strains that form the most considerable amount of biofilm, therefore, 
providing these strains with a possible advantage against the host antimicrobial defences (Conway 
et al., 2002). Although, there have been instances where studied showed there's no correlation 
between biofilm development and antibiotic resistance, and, in contrast, others studies that 
demonstrated the increase of antibiotic resistance in biofilms (Peters et al., 2009; Van Acker et al., 
2010). 
 1.7.10 Resistance to reactive oxygen species (ROS) 
 All bacteria, including Bcc strains, have mechanisms meant to cope with ROS created either 
from their own endogenous metabolism or from their environment. Since, CF patients suffer from 
chronic lung inflammation their sputum is a source of harmful ROS compounds (Drevinek et al., 
2008). Therefore, when these bacteria are subjected to stress there are different  genes activated 
in response  – the ohr gene, asmC gene – and the hfq gene, which is, also, important for stress 
tolerance of B.cepacia (Drevinek et al., 2008; Sousa et al., 2010). 
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1.8 Trimeric autotransporter adhesins 
 Trimeric autotransporter adhesins (TAAs) (Fig.6) are multimeric proteins found only in 
gram-negative bacteria. These proteins are important virulence determinants for Burkholderia 
strains being responsible for not only adherence but, also, biofilm formation, invasion and survival 
within eukaryotic cells (Mil-Homens & Fialho, 2011). Therefore, the trimeric autotransporter 
adhesins are an important intervenient in the adhesion process to extracellular matrix proteins 
(ECM) and to host cells (Linke et al., 2006). TAAs are multi-domain outer membrane proteins 
organized in modules which in this case means that there’s a membrane anchored C-terminal 
domain that forms a trimeric 12 stranded beta-barrel pore that allows the translocation of the 
passenger domain into the extracellular space, using a type V secretion system (Cotter et al., 2005). 
Also, the trimerization of these proteins is extremely crucial for their function and translocation as 
it provides TAAs with the stability needed for multivalent interactions (Lehr et al., 2010). 
   
Fig. 6: Trimeric autotransporter adhesin schematic representation (Adapted from Mil-Homens & 
Fialho., 2011).  
 
 The analysis of the B. cenocepacia genome revealed 74 TAA putative encoding sequences 
showing the large number of TAAs that Bcc genomes possess reflecting their large multireplicon 
genomes that may have been acquired through insertion of transposable elements and 
bacteriophages or through horizontal transfer of DNA fragments (Mil-Homens & Fialho, 2011). 
Additionally, the high number of TAAs found in these genomes might suggest their high genome 
plasticity and their ability to colonize and adhere to their hosts whether human or environmental, 
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even though density and number of TAAs varies among the Bcc members. Furthermore, the 
phylogenetic analysis and sequence alignment of the TAAs from the Bcc genomes showed, that the 
domain architecture is conserved, being the C-terminal translocator domain highly conserved (Mil-
Homens & Fialho, 2011). 
   Seven TAAs were annotated in the genome of B. cenocepacia J2315, five were identified 
on chromosome 2 – BCAM0219, BCAM0223, BCAM0224, BCAM2418 and BCAM1115- and, other 
two on chromosome 3 – BCAS0236 and BCAS0335- confirming the findings of Holden et al. 2009 in 
which chromosome 2 and 3 present the most of the virulence genes instead of chromosome 1 
where core functions are located on (Mil-Homens & Fialho, 2011). In addition, the adhesins 
BCAM0219 and BCAM0223 are part of a putative adhesin cluster (Fig.7) found only on 
B.cenocepacia strains of the ET12 lineage.  The mentioned adhesins are  contained within the 
mentioned cluster as three adhesins - BCAM0219, 0223, 0224 - one outer membrane protein- 
BCAM0220 - one sensor histidine kinase - BCAM0218 - and, lastly, two regulators - BCAM0221 and 
BCAM0222 (Mil-Homens et al, 2010). Moreover, it was suggested that, the co-transcribed  
BCAM0219 and BCAM0220 genes, and the TAAs genes BCAM0223 and BCAM0224 are regulated by 
the two present regulators while the sensor histidine kinase is responsible for sensing stimuli (Mil-
Homens et al, 2010). Furthermore, this adhesin cluster is placed upstream of the cci pathogenicity 
island, identified in B. cepacia J2315, which includes BCESM the epidemiological marker for 
virulent strains. The BCAM0224 gene was found to be unique to ET12 lineage B. cenocepacia (Mil-
Homens et al, 2010). 
 
  
 
 
 
 
 
 
Fig. 7: Genetic organization of the putative adhesin cluster. The numbers 218,219,220,221,222,223,224 and 
225 refer to the BCAM0219, 0223, 0224 and 0225 genes, respectively. The B. cepacia cci island is also shown 
(Mil-Homens et al., 2010). 
 
 As stated before, the TAAs are important to the virulence and adhesion of these bacteria to 
host cells. The BCAM0224 adhesin, was demonstrated to be able to bind to type I collagen, an 
important and abundant component of the extracellular matrix, and to play a role in the infection 
and virulence of B. cenocepacia infected CF patients. As, in fact, a BCAM0224 mutant displayed a 
marked decrease in virulence when compared with the wild type which implies the association of 
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TAAs with the proper attachment to host cells (Mil-Homens et al., 2010). In addition, this adhesins 
may play an important role in the development of bacteria aggregates because the BCAM0224 
mutation made B. cenocepacia incapable to do so, therefore, implying that this adhesin 
endogenous production is needed for cell-to-cell adhesion. TAAs are structurally rigid proteins as 
their 3D structure shows, in order to provide stability, three intrinsically connected trimers and 
when subjected to external force TAAs act as a spring which is consistent with their structure (El-
Kirat-Chatel et al., 2013). Additionally, it was demonstrated that the BCAM0224 TAA is capable to 
bind itself to specific receptors in the membrane surface of airway epithelial cells and form 
important invasion membrane tethers (El-Kirat-Chatel et al., 2013).   
 Furthermore, a functional study of  the trimeric autotransporter adhesin BCAM0223 as 
further demonstrated the necessary role of TAAs as they influence, not only, adherence to 
epithelial cells, but, also, serum resistance and hemagglutination (Mil-Homens & Fialho., 2012). 
The BCAM0223 mutant when compared with the wild strain  showed marked decrease of 
hemagglutination, as well as, impaired capability to adhere to extracellular matrix proteins, as 
vitronectin, and to form biofilms in polysterene surfaces pointing that this TAA might be needed for, 
not only, biofilm development, but, for persisting infection. This study, also, demonstrated that the 
classical complement pathway is necessary for the killing of the BCAM0223 mutant. As it, likewise, 
showed, whether the cells were afflicted by CF or not, the impaired ability of this mutant strain to 
adhere to respiratory epithelial cells, in comparison with the wild-type strain.  Besides, the 
adhesion decrease in the mutant implies that on one hand, non-CF cells expose a low level of 
BCAM0223 receptors, while, on the other hand, the mutant strains had a better invasion capacity 
than the wild-type. It is still not known why the BCAM0223 mutant is more efficient in invading 
host cells but one possible explanation is that in the absence of one of the TAAs, other multi-
functional TAAs and other adhesins, as well as, other cell surface components are capable to 
improve the efficiency of alternative invasion factors. Moreover, the role of the BCAM0223 adhesin 
was, also, evaluated in vivo in Galleria mellonella, and, although, moderated, the lack of the 
BCAM0223 adhesin diminishes the virulence of B. cenocepacia K56-2. Lastly, it is conceivable to 
suggest that this adhesin contributes to the virulence of B. cenocepacia (Mil-Homens & Fialho., 
2012). 
1.8.1 TAAs biological traits 
 As explained before, TAAs mainly have an adhesive function nevertheless they can usually 
accumulate other functions implicated in many other virulence roles (Tab.3). This following chapter 
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will describe the biological functions of some of these proteins. 
 
Tab. 3: Examples of characterized TAAs  
Organism Protein Functions References 
Y. enterocolitica 
Y. pseudotuberculosis 
YadA 
ECM binding. Autoagglutination 
Serum and phagocytosis resistance. 
Binding to  epithelial  cells and 
neutrophils.   
Invasion of epithelial cells. 
(Eitel & Dersch, 
2002; El Tahir et 
al., 2000) 
M .catarrhalis 
UspA1 
UspA2 
ECM and epithelial cell binding. 
Serum resistance. 
Bio film formation. (Holm et al., 2003; 
Pearson et 
al.,2002; Pearson 
et al.,2006 
Riesbeck et al., 
2006;) 
MID/Hag 
IgD binding. 
Adhesion to lung and middle ear 
epithelial cells 
Inhibitory effect on biofilm 
formation 
Hemagglutination, 
Autoagglutination. 
H. influenzae 
Hia 
 Hsf 
Epithelial cells binding. 
(Barenkamp & 
Geme, 
1996) 
S. enterica SadA 
Epithelial cells binding. 
Biofilm formation. 
Autoaggregation. 
(Raghunathan et 
al., 2011) 
 
 1.8.1.1 The Yersinia YadA adhesin 
  Several species from the Yersinia genus are considered pathogens, Yersinia enterolitica and 
Yersinia pseudotuberculosis are food-borne pathogens causative of gastrointestinal infections, 
while Yersinia pestis is the agent of the Plague, a zoonotic disease that mainly  affects small animals 
(Chain et al., 2004; Gu et al., 2007). 
 The YadA adhesin is a major virulence determinant of the Y. enterolitica species and it 
belongs to the TAAs family, which is enconded on the pYV virulence plasmid (el Tahir & Skurnik., 
2001; Linke et al., 2006; Zaleska et al., 1985). Many functions as causing infection, serum resistance, 
autoagglutination, phagocytosis resistance, invasion and, lastly, adhesion to the ECM components, 
have already been attributed to this adhesin (Balligand et al., 1985; Emody et al., 1989; 
Heesemann et al 1987; Shurnik et al., 1984; Tertti et al., 1992). The expression of the YadA protein 
is regulated and induced by a temperature of more than 37ºC (Shurnik & Toivanen, 1992). For the 
species Y. enterolitica this adhesin is most important as it binds to various types of fibrillar collagen, 
which include types I, II, III, V,  as well as the network forming collagen type IV (Schulze-Koops et 
al.,1992), but, in contrast, for Y. pseudotuberculosis, it binds to fibronectin instead of collagen and 
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laminin (Heise & Dersch, 2006). Furthermore, the YadA adhesin is, also, able to mediate the 
bacterial adhesion to different types of cells as epithelial cells, neutrophils and macrophages (Leo 
& Shurnik., 2011), in addition, to its ability to block the three pathways of the complement 
(Lambris et al., 2008), despite it being only important to Y. enterolitica persistence and not to Y. 
pseudotuberculosis (El Tahir & Shurnik., 2001). Lastly, the YadA adhesin ability to bind to collagen is 
crucial to the virulence of Y. enterolitica as its absence causes the avirulence of these bacteria in 
mice (Roggenkamp et al., 1995). 
 
1.8.1.2 The Moraxella catarrhalis adhesins 
 Moraxella catarrhalis is a gram negative bacterium commonly found in the lower 
respiratory tract where it causes severe infections and aggravation of obstructive pulmonary 
disease (Verduin et al., 2002). TAAs in  this species are, also, responsible for their ability to adhere 
to human epithelial cells (Lafontaine et al., 2000), as the adhesins UspA1 and UspA2 bind to ECM 
components like fibronectin and laminin, and additionally UspA2 is, as well, capable to bind to 
vitronectin (Hill et al., 2012; Tan et al., 2005; Tan et al., 2006). Moreover, the UspA2 protein is, also, 
associated with serum resistance and the ability of these bacteria to interfere with the 
complement pathway and the UspA1 protein is able to bind to the carcinoembryonic antigen 
related cell adhesion molecule (CEACAM) which is widely distributed on respiratory tract cells, and 
is involved in biofilm formation (Hill et al., 2012, Hill & Virji., 2003). 
 Besides, the UspA adhesins Moraxella catarrhalis, also, expresses the MID IgD-binding 
protein which is a TAA, as well (Pearson et al., 2002).  The MID adhesin has the ability to 
agglutinate erythrocytes and to bind to type II alveolar epithelial cells, mediate binding to type IV 
collagen, activate IgD+ B cells and provide Moraxella catarrhalis the ability to avoid interaction with 
host B cells through the secretion of antigen bearing outer membrane vesicles (OMV) (Bullard et 
al., 2007; Forsgren et al., 2003; Jendholm et al., 2008; Vidakovics et al., 2010). Additionally, M. 
catarrhalis devoid of MID adhesin were more efficiently cleared from mice lungs than wild type 
bacteria (Forsgren et al.,2004). 
 
  1.8.1.3 The Haemophilus influenzae Hia and Hsf adhesins 
 In the species H.influenzae two homologous TAAs were found - the Hia and the Hsf - that 
promote the adherence to respiratory epithelial cells (Spahich & St. Geme III, 2011). The Hsf 
adhesin has two binding domains- the HsfBD1 and the HsfBD2- that exhibit significant homology 
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with the Hia high affinity domain - HiaBD1 - and mediate adherence through a conserved acidic 
binding pocket. Furthermore, the Hsf adhesin has a third domain, the HsfBD3, which lacks the 
acidic binding pocket and the adhesive ability in Chang epithelial cells, despite, also, sharing 
similarities with the HiaBD1. Therefore, this last domain might have an important role in stabilizing 
Hsf fibers and facilitating Hsf-mediated adherence in a context of polysaccharide capsule (Cotter et 
al., 2005). 
 The other TAA expressed by H. influenzae is the Hia adhesin which promotes the adherence 
to several human epithelial cell lines. The Hia adhesin passenger domain contains two different 
binding pockets, which with different affinities interact with the same host cell receptor. 
Additionally, both domains were shown to be essential optimal bacterial adherence (Laarman et al., 
2002).    
 
 1.8.1.4 The Salmonella enterica SadA adhesin 
 The S. enterica SadA TAA is involved in promoting epithelial cell binding autoaggregation 
and biolfilm formation (Raghunathan et al., 2011). Nevertheless, it was found by further 
investigation that directly upstream to the adhesin gene, a small lipoprotein was predicted. This 
trimeric lipoprotein was named SadB and it was demonstrated to be co-expressed and directly 
influence the SadA TAA. The lipoprotein SadB was shown to be located in the inner membrane of 
Salmonella spp. and its absence reduced the amount of surface expressed SadA, as well as, its 
resistance to proteinase K implying that SadB is involved on the folding and exporting of the SadA 
TAA. Furthermore, the presence of this lipoprotein is required for the surface expression of SadA as 
the induced expression of both proteins showed higher signal levels of SadA than strains 
expressing only the sadA gene. In addition, the expression of both SadA and SadB, but not the 
expression of SadA alone, contributed to the development of SadA positive cells clusters (Grin et 
al.,2013)
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1.9 Lipid rafts in cell interactions  
 CF airways epithelial cells susceptibility to infection may arise due to a number of 
alterations, which provide receptors for the pathogens to adhere to, as , for example, CF cells show 
both increased sulfation of high molecular mass glycoproteins, fucosylation and decreased 
sialylation (Rhim et al., 2000; Xia et al., 2005). In addition, CF cells have a higher ratio of asialylated 
ganglioside 1 (aGM1) to sialylated ganglioside 1 GM1, and, also, higher expression of surface aGM1 
(Saiman & Prince, 1993). This is important because pathogens as P. aeruginosa, the most common 
species in CF infected airways, and Bcc species have been described to bind to asialylated 
glycolipids (Krivan et al., 1988; Saiman & Prince, 1993), as well as, to lipids receptors (Sylvester et 
al., 1996). The studies by Krivan et al and Sylvester et al, show contrasting results as the former 
demonstrated that Bcc strains bind to GalNAcbeta1-4Gal sequences containing glycosphingolipids 
which include aGM1 and aGM2, and did not bind to the GM1 and GM2 globosides, while, the later 
study indicated B. cenocepacia as able to bind to globotriosylceramides (Krivan et al., 1988; 
Sylvester et al., 1996). 
 Several pathogens interact with lipid rafts in order to entry host cells, lipid rafts can be 
found in eukaryotic cells namely in both their plasma and endossomal membranes and are 
composed of cholesterol, glycosphingolipids, and glycosylphosphatidylinositol (GPI) anchored 
proteins (Fig.8B) (Rosenberger, Brummel & Finlay., 2000, reviewed in Zaas et al., 2005). Lipid rafts 
exhibit many functions as polarized secretion, membrane transport, transcytosis across epithelial 
monolayers and the generation of cell polarity, as well as, playing an important role in signal 
traduction through their enrichment with many signalling molecules, as for instance, tyrosine 
kinases and lipid signalling intermediates (Rosenberger, Brummel & Finlay, 2000).  Furthermore, a 
growing number of pathogens admit the use of lipid rafts to gain entry into to host cells or the use 
of clustered lipid rafts which are assemblies of a number of lipid rafts, thought to be included in 
macromolecular transport. Pathogens that use clustered lipid rafts as a mean of endocytosis may 
be able to evade fusion with traditional lysossomes and, therefore, the contents can target a range 
of different cell compartments, which may help the spread of pathogens and their survival within 
host cells (Fig.8A) (reviewed in Zaas et al., 2005). Lipid rafts besides being important in the binding 
of toxins are, also, important in the adhesion and the binding of bacteria themselves. It was 
possible to assume the involvement of lipid rafts because of the observation, in bacterial entry 
sites, of proteins and raft associated lipids, in addition, to the need of cholesterol presence for 
bacterial invasion (Lafont & van der Goot, 2005). 
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 P. aeruginosa is among the wide range of bacterial pathogens that utilize lipid rafts as 
receptors, in which, is possible to find, for example, Escherichia coli, that was the first pathogen 
known to invade host cells via lipid rafts and Brucella abortus, which is the bacteria responsible for 
the most frequent zoonosis Brucellosis (Zaas et al., 2005). A study showed that lipid rafts are 
necessary for the uptake of P. aeruginosa bacteria, and to the location of CFRT to lipid rafts at sites 
of contact with epithelial cells during the initial interaction. This study, also, indicated, that 
cyclodextrin, a cholesterol depleting drug, is able to diminish the amount of CFRT found in lipid 
rafts. Furthermore, cyclodextrin treatment of cells demonstrated reduced uptake of bacteria in 
both cells expressing wild type CFRT and the ΔF508 mutation. In addition, the internalization levels 
of P. aeruginosa were further reduced by cyclodextrin treatment in cells expressing only ΔF508 
mutation in the absence of cyclodextrin. Therefore, these results imply, not only the requirement 
of cell surface CFRT, but, also, lipid rafts for the internalization of P. aeruginosa by epithelial cells 
(Kowalski et al., 2004). Moreover, these bacteria are, as well, capable to invade the alveolar space 
and adhere to and invade type I pneumocytes. P. aeruginosa showed inhibited invasion of 
pneumocytes with low doses of ciclodextrin, nystatin and filipin, but, in contrast, adherence to the 
pneumocytes was not affected by these cholesterol disruption drugs. Additionally, it was shown 
that not only the integrity of lipid rafts was necessary for P. aeruginosa endocytosis , but also, the 
tyrosine phosphorylation of specific lipid raft proteins as caveolin 2; plus, these bacteria might use 
this pathway of endocytosis in order to survive within a protected intracellular environment (Zaas 
et al., 2005a).   
 Brucella bacteria can avoid the macrophages bactericidal activity after their first contact 
with host cells and its infection is as well related with lipid rafts. In Brucella infection lipid-raft 
associated molecules as GPI anchored proteins, cholesterol and GM1 gangliosides are found 
macropinossomes containing Brucella bacteria from which the lysosomal glycoprotein LAMP-1  and 
the host-cell transmembrane protein CD44 were excluded (Jimenez de Bagues et al., 2005; Watarai 
et al., 2002, Vieira et al., 2010). Additionally, the interaction between the heat-shock protein 60 
and PrPC , a lipid-raft associated molecule, on macrophages contributes to the establishment of 
infection (Watarai et al., 2002, 2004). 
 Other pathogen that needs the contribution of lipid rafts to establish infection is N. 
meningitidis, that either causes a rapid evolving form of septicaemia or meningitis. Again, the use 
of a lipid depletion drug rendered N. meningitidis microcolonies sensitive to mechanical stress as 
they were found to be less tightly associated and more easily disrupted; only leaving a monolayer 
of bacteria in contact with the cells surface. Lastly, the disruption of this lipid microdomain, also, 
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affected the development of bacteria-induced cellular projections that surround the diplococci 
microcolonies; as treated endothelial showed reduction in these bacteria-induced cellular 
projections and cholesterol repletion allowed their development. So, the membrane reorganization 
brought on by N. meningitidis is dependent on the presence of membrane cholesterol for the 
integrity of lipid rafts, as well as, for the presence of the cellular projections that are relevant for 
the cohesion of microcolonies (Mikaty et al., 2009).  
 
Fig. 8: Schematic diagram showing the role of lipid rafts and caveolae in P. aeruginosa and B. abortus 
pathogenesis (A) and a classical lipid raft scheme (B) where membrane microdomains are enriched with 
cholesterol, sphingolipids and, also, possess associated proteins such as GPI- anchored proteins ( Adapted 
from Vieira et al., 2005; Adapted from Zaas et al., 2010).  
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1.10 Objectives 
 
 This study aims to further characterize the role of the B. cenocepacia’s TAAs in the binding 
to host cells, as the gateways used by these bacteria are still not known. For this purpose lipid rafts 
are regarded as a viable option for B. cenocepacia since they are used by P. aeruginosa and other 
pathogens to adhere, gain entry into cells and, therefore, cause infection. With this in mind 
adhesion and invasion assays were planned in order to evaluate the BCAM0224 TAA role in the 
adhesion and invasion of host cells by B. cenocepacia. The assays were executed using three 
different in vitro model epithelial cells, two bronchial epithelial cells lines, 16HBE14o₋ and 
CFBE41o₋ lines, and the A549 carcinomic human alveolar basal epithelial cell line. In these assays 
cell monolayers were infected with B.cenocepacia K56-2 and B.cenocepacia BCAM0224::Tp mutant 
after being subjected to a methyl-β-cyclodextrin (MβCD) treatment.  
In addition, this study also aimed to understand if the BCAM0220 and BCAM0219 operon 
exhibited the same sort of interaction demonstrated by the SadA and SadB Salmonella proteins.  
For this purpose, an experiment was planned to understand the workings of the referred 
operon. In this experiment a BCAM0220 negative mutant and an anti-BCAM0219 antibody were 
designed in an attempt to shed knowledge on this hypothesis. The mutant and the antibody would 
be used in adhesion and invasion assays so that it would be possible to understand if the 
BCAM0220 lipoprotein presence influenced BCAM0219 biogenesis. This experiment would allow 
us to understand if the BCAM0220 co-expression with BCAM0219 has direct influence on this 
protein biogenesis, therefore, implying that in this case TAA autotransport is assisted by other 
periplasmatic proteins. 
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2. Materials and Methods 
2.1 Bacterial strains and growth conditions 
Two different bacterial strains were used, the wild type B. cenocepacia K56-2 and B. 
cenocepacia  BCAM0224::Tp mutant, which as a thrimethoprim(Tp) resistance cassette inserted in 
the BCAM0224 TAA enconding gene. 
Both strains were cultured in similar conditions at 37°C with 250 rpm orbital agitation. The 
B. cenocepacia K56-2 strain was routinely cultured in Luria-Bertani Broth (LB) while the mutant 
strain was cultured in trimethoprim (150 mg/mL) LB supplemented media. 
When required for functional studies  both strains were grown in 24 wells plates, starting in, 
an initial OD640 of 0.2, in LB media containing NaCl (300 mM) and  H2O2 (10 mM, for  17 hours 
under microaerophilic conditions (< 5 % CO2 ) at 37°C with 60 rpm orbital agitation. 
 
2.2 Cell lines and cell culture 
 Three different cell lines were used. 16HBE14o₋ and CFBE41o₋  cells which are human 
bronchial epithelial cells, the former are normal lung cells expressing a functional CF 
transmembranar conductance regulator, the latter are homozygous for the ΔF508 mutation 
correspondent to a CF airway; and A549 cells which are carcinomic human alveolar basal epithelial 
cells. 
 The bronchial epithelial cell lines were ordinarily maintained in Minimum Essential Medium 
with Earle’s salt (MEM) supplemented with 10% fetal bovine serum (FBS), L- Glutamine (0.292 g/L) 
and penicillin/streptomycin (100 U/mL) in fibronectin/collagen coated flasks in a humidified 
atmosphere with 5% CO2 at 37°C. A549 cells were cultured in non-coated flasks in F-12 media 
supplemented with inactivated 10% FBS and 1% penicillin/streptomycin and maintained under the 
same atmosphere conditions. When the cells in the flask were 80% to 100% confluent, they were 
sub-cultured. To sub-culture 16HBE14o₋and CFBE 41o- cells the medium was removed , the cells 
were washed with  3 mL hepes buffered saline (HBS) then, 2 mL PET solution  was added( HBS, 10% 
polyvinylpyrrolidone, 0.2% EGTA and 0.25% trypsin with 0.02% EDTA) and the flask placed in the 
37°C incubator to allow the trypsin to work. After 5 minutes the flask was checked for cell 
detachment aiming to remove  > 95% of the cells from the flask surface. Finally, 5 mL medium was 
added to stop the trypsinization. The cells were repeatedly pipeted to break clumps, centrifuged at 
1200 rpm to pellet the cells and resuspended with 4 mL supplemented MEM medium before being 
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divided into 2 different flasks.  A549 cells, after removing the medium, were sub – cultured by, 
firstly being washed with 3 mL phosphate buffered saline (PBS) and scrapped of the flask surface. 
Secondly, 4 mL of F-12 media was added to resuspend the cells and divide them into new flasks. 
 Then, the cell flasks were placed in the incubator at 37°C with humidified atmosphere 5% 
CO2. 
 
2.3 Adhesion and invasion assays of human epithelial cells 
 Both adhesion and invasion assays were carried out on three cell lines: 16HBE14o₋, 
CFBE41o₋  and A549  . 
Firstly, cells were seeded on 24 wells plates (5 x 105 cells per well) in supplemented media  
for 24 hours at 37°C in humidified 5 % CO2  containing atmosphere. Then, cells were washed with 
HBS or PBS, 16HBE14o₋, CFBE41o₋ or A549 cells, respectively, and maintained in non-supplemented 
media; before being treated or not with MβCD (500mg/mL) for 30 minutes. 
For these assays, B. cenocepacia K56-2 and BCAM0224::Tp were used to infect the cell 
monolayers at a multiplicity of infection (MOI) of 50:1 (bacteria per epithelial cell). After infection 
the 24 well plates were centrifuged at 700g for 5 minutes. Subsequently, in order to allow bacterial 
adhesion, the infected monolayers were incubated at 37°C in 5% CO2 atmosphere for 30 minutes. 
Afterwards, the cells were washed 3 times with PBS and lysed with 200 µL of lysis buffer (10 Mm 
EDTA and 0.25 % Triton X-100) for 30 minutes at room temperature. 
For the invasion assays, the infected cells were incubated at 37°C in 5% CO2 for 2 hours to 
allow bacterial entry. After this, the cells were washed 3 times with PBS and a combination of 
amikacin and ceftazidime (3 mg/mL each) was added, thereon another 2 hours incubation period 
followed. To confirm the efficiency of the antibiotic treatment the supernatants were plated. 
Finally, the cell monolayers were again washed with PBS 3 times and lysed with lysis buffer (10 mM 
EDTA, 0,25% Triton X-100) for 30 minutes as in the adhesion assays. 
The bacteria quantification, in both experiments, was done by serial dilution plating of the 
cell lysates and the results were expressed as percentage of the bacterial dose applied. 
 
2.4 Plasmids and primers 
 All plasmids used and generated for this study are shown in Table 4 as well as a list of 
primers is shown in Table 5.  To design these primers B. cenocepacia K56-2 genomic sequence was 
used as a template 
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Tab. 4: Plasmids generated during the course of this study 
Plasmid Description Source 
pDrive Cloning vector , Amp
R
,Km
R
 Quiagen 
pUC-TP 
Derivative of pUC-GM, with ampicilin resistance 
gene 
(Sokol et al .1999) 
pK18 Cloning vector, Km
R
  
pET23a(+) Cloning vector, Amp
R
 Novagen 
pET22b(+) Cloning vector, Amp
R
 Novagen 
pDF1 
Cloning vector pDrive with complete BCAM0220 
and flanking intergenic regions 
This study 
pDF2 
Cloning vector pDrive with complete  BCAM0220 
and Tp cassette 
This study 
pDF3 
Cloning vector pK18 with fragment BCAM0219223-
503aa 
This study 
pDF4 
Cloning vector pET23a(+) with fragment 
BCAM0219620-902aa  
This study 
pDF5 
Cloning vector pET23a(+) with fragment 
BCAM021966-528aa  
This study 
pDF6 
Cloning vector pET23a(+) with fragment 
BCAM0224633-854aa  
This study 
pDF7 
Cloning vector pET-22b(+) with fragment 
BCAM0219223-503aa 
This study 
pDF8 
Cloning vector pET-22b(+) with fragment 
BCAM0219620-902aa 
This study 
pDF9 
Cloning vector pET-22b(+) with fragment 
BCAM0224633-854aa 
This study 
pDF10 
Cloning vector pET22b(+) with fragment  
BCAM0224224340-638aa  
This study 
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   Tab. 5: PCR amplification primers.  
Primer  5’-3’ Sequence 
M220KpnF CGG GGT ACC CAT CCG ACT GAT TCC GAA TCC A 
M220HindR TTT AAG CTT AGA TTT GCG CGG CAA TCG 
BCAM0219223-503Ndefwd TTT CAT ATG GCA GTG ACG TAC GAC AAG AA 
BCAM0219223-503Xhorev AAA CTC GAG CGC GTT GAC TTG 
BCAM0219620-902Bam_fwd CGG GAT CCG CAG TGA CGT ACG ACA AGA A 
BCAM0219620-902Hind_reverse CCC AAG CTT CGC GAC GTT CTT GAC TTG C 
BCAM021966-528Ndefwd TTT CAT ATG AAT GGT TCG CTG ACG CTT TGC 
BCAM021966-528Hindrev TTT AAG CTT CAC GTT AAT CTG CCG CTG CCG CTG AA 
BCAM022454-323Ndefwd TTT CAT ATG GCG GAA GTG TGT ACG GCA GAA 
BCAM022454-323Xhorev AAA CTC GAG GGT CTG CAG GTC GAT GT 
BCAM0224633-854Nde TTT CAT ATG GTG ACG GTG TCG CAG CTT C 
BCAM0224633-854Hind TTT AAG CTT GAC GTT CGT GAT CTG GCG TT 
BCAM0224340-638Nde TTT CAT ATG GCA AAC CTG ACC GTC GGC AA 
BCAM0224340-638Xho AAA CTC GAG AAG CTG CGA CAC CGT CAC GA 
 
2.5 DNA manipulation techniques 
 Plasmid DNA was extracted following a Miniprep extraction protocol or using the ZR 
Plasmid Miniprep-Classic kit (Zymo research) by following the manufacturer instructions. Total DNA 
extraction was done using the DNeasy Blood & Tissue Kit (Quiagen) following the manufacturer 
instructions. 
 The amplification reactions occurred in a volume of 25 µL each containing 20 ng of B. 
cenocepacia K56-2 DNA, 1x amplification buffer, 1.5 mM MgSO4, 10 mM of primer forward and 
primer reverse, 2.75 U Platinum Taq DNA Polymerase (Invitrogen), 1x or 2x Enhancer solution and 
(Invitrogen) 0,2 mM deoxyribonucleotides. All melting temperatures and extension time were 
optimized for each set of primers.     
 
2.6 BCAM0220 insertion mutant construction 
 By PCR a 1.07Kb fragment of the BCAM0220 gene was amplified from B. cenocepacia K56-2 
DNA, using primers M220KpnF and M220HindR, which contain the KpnI and HindIII restriction sites, 
respectively. The amplification was carried out, after an initial denaturation at 95°C for 2 min, for 
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35 cycles consisting of denaturation at 95°C for 30s, annealing at 55°C for 30s and extension at 
72°C for 1min, final extension was carried out at 72°C for 7 min.   Then, the PCR product was 
digested with both KpnI and HindIII before being cloned into the pDrive cloning vector which was 
beforehand digested using the same enzymes, as well.   From pUC-Tp, the 1.01Kb trimethoprim 
cassette containing fragment was extracted through PstI digestion and, then, inserted in the only 
PstI restriction site of the BCAM0220 fragment. 
 After, obtaining the construction comprising the pDrive vector, BCAM0220 fragment and 
the Tp cassette was obtained it was introduced in B. cenocepacia K56-2 by eletroporation (25 µF, 
2.5 Kv, 200 Ω).  The transformants obtained were selected on LB agar supplemented with 
trimethoprim (150 mg/mL) for 48 hours at 37°C. To distinguish between single and double 
crossover mutants trimethoprim-resistant colonies were screened by replica plating for kanamycin 
(600 mg/mL) sensitivity as the pDrive cloning vector has a kanamycin resistance gene. Colonies 
which only showed trimethoprim resistance were chosen as candidate insertion mutants and their 
total DNA was extracted. 
 Lastly, the candidate insertion mutants were characterized by PCR using the above 
mentioned primers for the fragment amplification, after total DNA extraction. For this confirmation 
amplification the extension time was changed to up 2 min. This PCR approach would allow the 
identification of BCAM0220 deficient B. cenocepacia.       
  
2.7 Recombinant proteins expression 
Different truncated fragments were generated with their specific sizes and primers for 
generating the polypeptides. The different truncated fragments were created form several TAAs 
such as BCAM0219 and BCAM0224 using head and stalk frames as a template. All  BCAM0219223-
503 , BCAM0219620-902 and  BCAM021966-528 fragments were generated using the head frame of the 
BCAM0219 TAA as template and the fragments  BCAM022454-323 , BCAM0224633-854 and 
BCAM0224340-638 the BCAM0224 TAA head and stalk frame, respectively (Fig.9). 
The fragments were amplified by PCR using specific primers to introduce NdeI and XhoI 
restriction sites to BCAM0219223-503, BCAM022454-323, BCAM0224340-638 fragments, NdeI and HindIII 
restriction sites to BCAM021966-528 and BCAM0224633-854 fragments. BCAM021966-528 , BCAM022454-
323 ,  BCAM0224633-854 and BCAM0224340-638  fragment amplification occurred following a scheme of 
denaturation at 95°C for 30s, annealing at 57°C for 30s and extension at 72°C for 1 min repeated 
for 35 cycles and final extension at 72°C for 7 min; after an initial denaturation at 95°C for 2 min. 
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The amplification of fragments BCAM021966-528 was carried out in similar conditions except for the 
annealing which occurred at 53°C for 30s. 
Fragment BCAM0219620-902 was amplified by PCR using specific primers to introduce BamHI 
and HindIII restriction site. Firstly, the BCAM0219620-902 PCR product was cloned into pK18 cloning 
vector. The resulting plasmid was first transformed by eletroporation (25 µF, 2.5 Kv, 400 Ω) into to 
the non-expressing E. coli αDH5 which was incubated in the presence of LB ampicilin (150 mg/mL) 
containing media plates at 37°C overnight. Before, plating a mixture of isopropyl-1-thio-β-D-
galactoside (IPTG) (25 mg/mL) and X-GAL (25 mg/mL) was added to the media plates to allow 
transformant colonies selection by α- complementation as pK18 has a lacZ gene.   Then, all PCR 
products were cloned into pET22b(+) or pET23(+) cloning vectors. 
The resulting plasmids were transformed by eletroporation (25µF, 2.5 Kv, 400Ω) into E. coli 
αDH5 which was incubated in the presence of LB ampilicin (150mg/L) containing media plates at 
37°C overnight. 
Thereafter, the plasmidique DNA was extracted and the plasmids coding for the fragments 
were checked for the specific fragment presence by restriction enzyme digestion before being 
transformed into E. coli BL21(DE3) that, also, was incubated in LB plates supplemented with 
ampicilin (150 mg/mL) at 37°C overnight. Then, the strain was grown overnight with 250 rpm 
orbital agitation at 37°C in LB media containing ampicilin (150mg/mL), for subsequent 
overexpression.   
For overexpression, the strain was grown to an initial OD640nm= 0.1 previous to inoculation 
into fresh supplemented media. After this, the strain was grown, for approximately 2 hours, to an 
OD640nm= 0.6-0.8 followed by 1mM, 0.2mM and 0.5mM IPTG induction. Later samples were taken, 
after 2 hours, 3 hours and 4hours growth at an OD640nm=0.5. The samples taken were maintained in 
sample buffer at -20°C. 
 Afterwards, recombinant protein overexpression was verified by whole-cell protein 
electrophoresis. 
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Fig. 9: Generated fragments TAA region overview. Blue represents the peptide signal. Gray represents the 
membrane anchor. Red represents the YadA head like protein domains. Green represents the neck like 
domains. (http://toolkit.tuebingen.mpg.de/dataa, 30/102014, 17h). 
 
2.8 Whole-cell protein electrophoresis 
   In order to verify recombinant protein overexpression, SDS-Polyacrylamide  gels (SDS-
PAGE) were cast with the appropriate percentages of polyacrylamide, according to the expected 
recombinant protein molecular weight. 5% stacking gels and 15% resolving were prepared by 
mixing the respective amount of 30% acrylamide (Sigma-Aldrich), 10% ammonium persulfate, 10% 
SDS, TEMED, water and 1.5 or 1M Tris for the resolving and stacking gels, respectively. 
 The electrophoretic conditions used were 150V for about 1h30min. Then, the SDS-PAGE 
was stained with Commassie Blue.   
 
2.9 Statistical analysis  
 All statistical data analysis was done using Microsoft Excel (Microsoft) by computing the 
percentage of bacterial adhesion and invasion for both MβCD treated and untreated cells. The 
results were expressed as a ratio of the wild type and corrected with bacterial dose applied. The 
ANOVA test for significance was used for relative comparisons, considering a p-value<0.05 as 
statistical significant.  
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3. Results 
  
 3.1 B.cenocepacia adherence and invasion assays of epithelial cells. 
 To access whether lipid rafts are involved or not in adherence and invasion of airway 
epithelial cells by B. cenocepacia K56-2, adhesion and invasion assays were performed using three 
different in vitro model bronchial epithelial cells, 16HBE14o- and CFBE41o- , which have a CF and 
non-CF phenotype, respectively, and, A549 carcinomic human alveolar basal epithelial cells. Cell 
monolayers were infected with B. cenocepacia K56-2 and B. cenocepacia BCAM0224::Tp mutant 
after being subjected to a lipid depletion treatment with MβCD (500 mg/mL). All adherence and 
invasion assays for all cell lines were done with both treated and untreated cells in order to allow 
comparison between the different conditions. 
 
 3.1.1 CFBE41o- adhesion and invasion assays
Fig. 10: Effect of MβCD (10 mM) CFBE41o- host cell treatment on B. cenocepacia K56-2 (K56-2) and 
BCAM0224::Tp mutant capacity of adhesion (A) and invasion (B). A) In both B. cenocepacia K56-2 (K56-
2+MβCD) and mutant (BCAM0224::Tp+MβCD) infection of treated CFBE41o- cells the percentage of 
adhesion showed no statistical difference (NS). Only the mutant’s (BCAM0224) adhesion to untreated cells 
was significantly decreased (**p<0.01). B) Both B.cenocepacia K56-2 (K56-2+MβCD) and mutant 
(BCAM0224::Tp+MβCD) invasion of treated CFBE41o- cells shows no statistical difference (NS). Only the 
mutant’s (BCAM0224) invasion of CFBE41o- untreated cells was significantly decreased (*p<0.05). Results are 
shown as percentage of the initial dose applied.
 
 Both adhesion and invasion percentages for this cell line assays are depicted in Fig.10. As 
shown Fig.10A, the BCAM0224-negative mutant adhered less efficiently than the wild type strain 
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to the untreated cells (**p<0.01). Nevertheless, in contrast, to these results, when in the presence 
of treated cells both strains seem to demonstrate increased adherence to host cells, but there was 
no statistical difference in the results (NS). Furthermore, the invasion assays, in Fig.10B, the results 
indicate that both  B. cenocepacia K56-2 and B. cenocepacia BCAM0224::Tp mutant demonstrate 
equal percentages of invasion (NS) when comparing  both strains invasive ability whether the cells 
were treated or not. Additionally, the BCAM0224-negative mutant shows a decreased percentage 
of invasion (*p<0.05). 
 
3.1.2 A549 adhesion and invasion assays   
Fig. 11: Effect of MβCD (10 mM) A549 host cell treatment on B. cenocepacia K56-2 (K56-2) and 
BCAM0224::Tp mutant capacity of adhesion (A) and invasion (B). A) In both B. cenocepacia K56-2 (K56-
2+MβCD) and mutant (BCAM0224::Tp+MβCD) infection of treated A549 cells the percentage of adhesion 
was significantly increased (***p<0.001). Only the mutant’s (BCAM0224) adhesion to untreated cells was 
significantly decreased. B) Both B.cenocepacia K56-2 (K56-2+MβCD) and mutant (BCAM0224::Tp+MβCD) 
invasion of treated A549 cells shows no statistical difference (NS). Only the mutant’s (BCAM0224) invasion 
of A549 untreated cells was significantly decreased (***p<0.001).  Results are shown as percentage of the 
initial dose applied.  
   
 In Fig.11 are presented the results of the assays performed with the A549 cell line. The 
results in Fig.11A show a marked increase of adhesion percentage for B. cenocepacia K56-2 and B. 
cenocepacia BCAM0224::Tp mutant in both MβCD treated cells (***p<0.001). When A549 cells 
lose lipid rafts the capacity of B. cenocepacia wild type and mutant, became enhanced. However, 
in invasion (Fig. 11B) the results show no significant differences in the B. cenocepacia K56-2 and B. 
cenocepacia BCAM0224::Tp mutant capacity of invasion when A549 cells lose lipid rafts.  In 
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addition, as shown in Fig. 11A and 11B the BCAM0224-negative mutant adhered and invaded 
untreated cells less efficiently (***p<0.001). 
 
3.1.3 16HBE14o- adherence and invasion assays 
 The adhesion and invasion assays for the 16HBE14o- cells yielded variable results. Despite 
several experiments a valuable result couldn’t be achieved. Therefore, it was not possible to 
understand if the MβCD cells treatment affected the bacteria’s adhesion and invasion ability. 
 
3.2 BCAM0220 insertion mutant construction 
 The BCAM0220 gene, which encodes a lipoprotein in the putative adhesion cluster, was 
chosen for the construction of this insertion mutant because this gene was demonstrated to be in 
the same operon as the BCAM0219 gene, suggesting a possible interaction between the two; as 
seen for the S. enterica SadB lipoprotein (Grin et al., 2014). 
 The methodology for the mutant construction was described in the Materials and Methods 
chapter, the complete BCAM0220 gene with flanking intergenic regions was amplified by PCR, 
which was cloned into the pDrive cloning vector, and, then the trimethoprim cassette containing 
fragment was inserted in the only PstI restriction site of the BCAM0220 fragment. This construction 
was then introduced in B. cenocepacia K56-2 by eletroporation. Finally the identification of 
BCAM0220 deficient B. cenocepacia was executed by PCR. As the plasmid pDrive is non replicative 
in B. cenocepacia, if the double crossover recombination occurs, we’ll obtain the amplification of 
the BCAM0220 fragment (1.07 Kb) plus the trimethoprim cassette (1.01 Kb), performing an 
amplification of 2.08 Kb. However, if only a single recombination event occurs pDF2 would be 
integrally inserted into the B. cenocepacia genome and the BCAM0220 gene remains intact, 
leading on two amplification products, one with 1.07 Kb , and another with 2.08 Kb. 
Unfortunately, the BCAM0220 insertion mutant with double recombination was not 
obtained after many attempts, only the first recombinant step has occurred (Fig.12). As presented 
in Fig.12, it is possible to note the presence of two stained bands, a less stained band marked at 
the 2 Kb size and a strongly stained band marked at approximately 1 Kb. Nevertheless, the 
excepted result should be a single band at the 2 Kb , confirming the insertion of the trimethoprim 
cassette in the BCAM0220 gene. 
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Fig. 12: Screening of a BCAM0220 insertion mutant. Lane 1- Colony 1 with 1000bp and 2000bp. L- 1Kb DNA 
ladder. 
 
3.3 BCAM0219 and BCAM0224 truncated recombinant proteins construction 
 Several head and stalk frames from the BCAM0219 and BCAM0224 TAAs were used as 
templates in order to understand which was better to facilitate the construction of the truncated 
proteins. Then, followed the overexpression of the expected truncated protein, after the different 
DNA fragments were obtained, subsequently cloned into the pET22b(+) or pET23(+) cloning vectors 
and introduced into E. coli BL21(DE3). 
 Unfortunately, overexpression of the truncated proteins was not achieved and the reasons 
possible for such will be discussed in the following chapter. Additionally, the results for the proteins 
for which the overexpression step was reached are presented in Fig.13 and Fig.14 that shows the 
cast SDS-polyacrylamide gels for the truncated proteins BCAM0219223-503, BCAM0219620-902, 
BCAM021966-528 and BCAM0224633-854. As is shown in Fig. 13 and Fig.14 overexpression was not 
obtained as no distinctly marked yield of protein is observed in comparison with the initial time 
sample (T0) that was taken before the IPTG induction. The expected proteins BCAM0219223-503 and 
BCAM0219620-902 would have a predicted size of 29KDa and 30KDa, respectively, and the remained 
truncated proteins would have approximately the same size. 
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Fig. 13: SDS-PAGE BCAM0219223-503 and BCAM0219620-902 protein analysis. A to B - BCAM0219223-503 protein 
SDS-PAGE overexpression analysis. C to D - BCAM0219620-902  protein SDS-PAGE overexpression analysis. 1 to 
2- BCAM0219620-902  protein low overexpression as a result of the 1, 0,2 and 0,5mM IPTG induction. T0- 
initial time sample before IPTG induction; T2- 2 hours after IPTG induction sample; T3- 3 hours after IPTG 
induction sample; T4- 4 hours after IPTG induction sample; L- ladder. 
 
 
 Also, as stated before, in Fig.13 A and Fig.14 B there is no BCAM0219223-503 protein 
overexpression as all  whole cell protein profiles (T2,T3,T4), in different IPTG conditions used,  are 
identical to the initial time (T0) sample in which no protein overexpression was induced. However, 
in Fig. 13 C and D  low protein overexpression can be observed; nevertheless the protein 
overexpressed does not exhibit the predicted size of 30KDa but instead a size of  25KDa, therefore, 
indicating that this is not the protein expected. 
 
Fig. 14: SDS-PAGE BCAM021966-528 and BCAM0224633-854 protein analysis. A - BCAM021966-528  protein SDS-
kDa 
35 
25 
       T0     T2   T3     T4    T0   T2    T3    T4        T0     T2   T3     T4    T0   T2    T3    T4 
     T0     T2      T3    T4     T0      T2    T3    T4         T0      T2       T3      T4 kDa 
35 
25 
1 mM IPTG 0,5 mM IPTG 1 mM IPTG 0,5 mM IPTG 
0,2 mM IPTG 1 mM IPTG 0,5 mM IPTG 
0,2 mM IPTG 
1 
2 
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PAGE overexpression analysis; B to C – BCAM0224633-854aa protein SDS-PAGE overexpression analysis. T0- 
initial time sample before IPTG induction; T2- 2 hours after IPTG induction sample; T3- 3 hours after IPTG 
induction sample; T4- 4 hours after IPTG induction sample;L- ladder. 
 
 
  Fig.14 shows that there was no overexpression for the expected BCAM021966-528 (Fig.14A) 
and BCAM0224633-854 (Fig14B) truncated proteins, as well, because, as before, the whole-cell 
protein profiles are identical to the T0 sample taken for all the IPTG conditions utilized. 
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4. Discussion 
 
4.1 Lipid rafts do not interfere in the adherence and invasion of epithelial cells by B. cenocepacia. 
 As mentioned before lipid rafts act as a point of adherence and invasion to host cells for 
various pathogens, such as P. aeruginosa, the most common pathogen in CF patients, therefore, 
lipid rafts would be a probable gateway to B. cenocepacia invasion of host cells through the TAAs 
binding. 
 However, the results obtained through the B.cenocepacia K56-2 and BCAM0224::Tp mutant 
adhesion and invasion assays revealed that lipid rafts do not interfere in the ability of these 
bacteria to either adhere and or gain entry into host cells despite their phenotype. Furthermore, 
surprisingly, both wild type and mutant strain show, in some cases, an increased ability of adhesion 
in the presence of CFBE41o- and A549 treated cells whereas the percentages of invasion for both 
cell lines show no significant differences. 
 Moreover, in the presence of disrupted lipid rafts the binding of either B. cenocepacia K56-2 
or BCAM0224::Tp mutant should have been impaired if lipid rafts were to be used as binding sites. 
In contrast, the absence of the BCAM0224 TAA and the disruption of the lipid rafts did not disturb 
the bacteria’s capacity of adhesion and invasion. Even though, the wild type strain percentage of 
adhesion and invasion is higher than that of the mutant strain, as expected. The compared 
percentages of invasion and adhesion for both B. cenocepacia K56-2 and the BCAM0224::Tp 
mutant for treated and non-treated cell indicate the bacteria's ability to keep invading host cells in 
the absence of lipid rafts. 
  Overall, these bacteria TAAs were able to mediate the binding and invasion of host cells in 
the absence of lipid rafts, therefore, demonstrating, that, in contrast with many other organisms, 
lipid rafts are not used as gateways by B. cenocepacia adhesins. 
 
4.2 BCAM0220 negative mutant construction 
 As seen in the results chapter the intended second recombination event did not happen 
and, therefore, it was not possible to obtain the BCAM0220::Tp mutant. Homologous 
recombination is a process that results in genetic exchange between homologous DNA sequences 
from two different sources. The pDF2 generated plasmid which was introduced by eletroporation 
into B. cenocepacia K56-2 and the chromosomes of B. cenocepacia are the two different sources. 
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Nevertheless, before discussing the mechanisms of recombination of the introduced plasmid this 
same transferred DNA faces three different fates:  degradation by restriction enzymes, replication 
by itself or it may recombine with the host chromossome. For this study the objective was to 
achieve the last option, the recombination of the Tp cassette interrupted BCAM0220 gene into one 
of the chromosomes of B. cenocepacia.  This method is based on the integration of the generated 
plasmid pDF2 into a chromosome by a single crossover recombination event that is followed by 
resolution of the integrated DNA by a second recombination event which results in the 
replacement of the original BCAM0220 gene with the inactivated gene, i.e., the Tp cassette 
interrupted BCAM0220 gene. However, in this study, the PCR analysis of a mutant candidate 
revealed that only a single crossover happened as a 1071bp fragment was amplified indicating the 
presence of an original wild type gene. Even though a 2000bp fragment was, as well, amplified, in 
order to obtain mutant the only amplified sequence should be that of the disrupted BCAM0220 
gene signalling the occurrence of a second crossover and, therefore, the replacement of the 
original BCAM0220 gene. Although, the construction of the BCAM0220 insertion mutant was not 
successful in this study; this method has already provided stable mutants as for example the 
BCAM0223 negative mutant (Mil-Homens et al., 2012), which indicates this method as appropriate 
to the construction of this mutant. 
 Furthermore, a trimeric lipoprotein was already described to aid in the biogenesis of an 
autotransporter in Salmonella (Grin et al.2014), therefore, if the mutant had been constructed it 
would help to learn if the BCAM0220 outer-membrane lipoprotein assists the TAA BCAM0219 in its 
binding or biogenesis as both were demonstrated to be an operon in the adhesin putative cluster. 
 
4.3 BCAM0219 and BCAM0224 truncated recombinant protein construction 
 In this study, the BCAM0219 and BCAM0224 recombinant truncated protein construction 
was unsuccessful, as only low or no overexpression of the target truncated proteins was achieved.  
There are several reasons that impede the expression truncated proteins and the problems often 
lie in a harmful effect that the heterologous protein causes on the cell.  When low or no 
recombinant protein production happens the problem, usually, lies with protein toxicity, which 
could interfere with the proliferation of the microorganism resulting in a slow growth rate, or 
codon bias, that leads to the depletion of low abundance t-RNAs resulting in  amino acid 
misincorporation and/or truncation of the polypeptide which, in  turn affects the heterologous 
protein expression, and lastly, the recombinant protein might have been degraded by the cell 
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mechanisms as it may have been recognized as a faulty protein or lacking a proper signal 
specifically directing it (Rosano & Ceccarelli, 2014). 
 Several strategies can be employed to overcome the lack of recombinant protein expression, 
in order to increase the protein yield as, for example, changing the vector, host and the culture of 
the recombinant host strain, co-expression of other genes (e.g. another protein that stabilizes the 
desired protein) and changing the gene sequences, which may help increase expression and the 
proper folding of the desired protein (Rosano & Ceccarelli, 2014). Therefore, in this study as 
overexpression of all protein of interest was not yielding results, the initially used vector pET23(+) 
was changed for the pET22(+) cloning vector which encodes a signal sequence specifically directing 
the protein to the membrane and distinct  frame sequences were used as templates which resulted 
in different generated fragments listed in the Materials and Methods chapter.    
 Although, after using the pET22(+) vector,  low protein overexpression could be observed in 
Fig.13 C and D in boxes 1 and 2 of the results chapter, the protein overexpressed is not the 
expected BCAM0219620-902, but, instead another protein. Such occurrence can be explained by the 
out of frame construction of the pDF8 generated plasmid which resulted in the translation and 
expression of a foreign protein as the available ORF was not enconding the protein of interest, but, 
instead a different protein. 
 Lastly, successfully obtaining the BCAM0219 antibody would enable the study of the 
possible interaction between the BCAM0220 protein and the BCAM0219 TAA. As it would allow us 
to understand how the absence of the BCAM0220 protein would affect the BCAM0219 TAA 
biogenesis, and, therefore, the antibody of interest would reveal the presence or absence of the 
BCAM0219 protein at B. cenocepacia's membrane. 
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5. Conclusion and future perspectives 
 In conclusion, this study allowed to understand that the lipid rafts do not interfere in the B. 
cenocepacia adhesion and invasion of CF airway epithelial cells, in contrast, with microorganisms 
as P. aeruginosa, the most prevalent pathogen in CF patients, B. abortus and N. meningitidis 
(Jimenez de Bagues et al., 2005; Mikaty et al,2009; Vieira et al., 2010;Watarai et al., 2002). So, in 
future studies the aim might be to search for a novel receptor candidate that helps to further 
understand the binding of the TAAs and the way this adhesins interfere in B. cenocepacia infection. 
A viable candidate to study would be the tumour necrosis factor receptor 1 (TNRF1) as B. 
cenocepacia BC-7, a ET-12 lineage strain binds to this receptor through an undefined bacterial 
ligand that is not cable pili (Sajjan et al., 2008). 
  Furthermore, in what concerns the BCAM0219 antibody construction a new plasmid 
should be generated with pET22(+) vector in addition to the  BCAM0219620-902 introduced in the 
correct frame. 
 Finally, the objective of this study to understand if cooperation between the both 
BCAM0220 and BCAM0219 proteins exist was not fulfilled as; unfortunately both the needed 
antibody and mutant were not successfully generated. 
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